Ramireddy Bommireddy

6PUBLICATIONS
16CO-AUTHORS
Cancer geneticsSolid tumoursMedical molecular engineering of nucleic acids and proteinsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 09, 2024
Chemoprevention of Head and Neck Cancer: A Review of Current Approaches and Future Perspectives.

Sanghoon Han, Ramireddy Bommireddy, Pauline Kim

|May 25, 2024
Tumor-Intrinsic Enhancer of Zeste Homolog 2 Controls Immune Cell Infiltration, Tumor Growth, and Lung Metastasis in a Triple-Negative Breast Cancer Model.

Lenore Monterroza, Maria M Parrilla, Sarah G Samaranayake

|Jun 24, 2022
Influenza Virus-like Particle-Based Hybrid Vaccine Containing RBD Induces Immunity against Influenza and SARS-CoV-2 Viruses.

Ramireddy Bommireddy, Shannon Stone, Noopur Bhatnagar

|Aug 27, 2021
Dendritic Cells Pulsed with Cytokine-Adjuvanted Tumor Membrane Vesicles Inhibit Tumor Growth in HER2-Positive and Triple Negative Breast Cancer Models.

Luis E Munoz, Lenore Monterroza, Ramireddy Bommireddy

|Jun 13, 2020
Tumor membrane-based vaccine immunotherapy in combination with anti-CTLA-4 antibody confers protection against immune checkpoint resistant murine triple-negative breast cancer.

Christopher D Pack, Ramireddy Bommireddy, Luis E Munoz

|Apr 17, 2020
Tumor Membrane Vesicle Vaccine Augments the Efficacy of Anti-PD1 Antibody in Immune Checkpoint Inhibitor-Resistant Squamous Cell Carcinoma Models of Head and Neck Cancer.

Ramireddy Bommireddy, Luis E Munoz, Anita Kumari

Pageof 1

Frequent Collaborators

2 joint publications

Dong M Shin

2 joint publications

Periasamy Selvaraj

1 joint publications

Zhuo G Chen

1 joint publications

Nabil F Saba